Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 31 Breast Neoplasms 25 Fallopian Tube Neoplasms 21 Multiple Myeloma 18 Carcinoma, Ovarian Epithelial 14 Lymphoma 8 Triple Negative Breast Neoplasms 4 Recurrence 3 Neoplasms, Plasma Cell 3 Hodgkin Disease 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Hematologic Neoplasms 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1

Interventions

Temozolomide 52 Bevacizumab 33 Radiotherapy 26 Radiation 12 Erlotinib Hydrochloride 12 Radiotherapy, Intensity-Modulated 8 Radiotherapy, Conformal 8 Irinotecan 6 Vorinostat 5 Sorafenib 5 Sirolimus 5 temsirolimus 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 Carmustine 4 veliparib 3 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Radiosurgery 3 Everolimus 3 Dasatinib 3 Bortezomib 3 vandetanib 2 tandutinib 2 sargramostim 2 poly ICLC 2 pembrolizumab 2 pazopanib 2 ferric pyrophosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡